Founder BRCA 1 and 2 Mutations among a Consecutive Series of Ashkenazi Jewish Ovarian Cancer Patients

By Tobias D.H.   Eng C.   McCurdy L.D.   Kalir T.   Mandelli J.   Dottino P.R.   Cohen C.J.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 148-151

Elsevier

Access to resources Recommend Favorite

Germline Mutations of theBRCA1andBRCA2Genes in a Breast and Ovarian Cancer Patient

By Randall T.C.   Bell K.A.   Rebane B.A.   Rubin S.C.   Boyd J.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 432-434

Elsevier

Access to resources Recommend Favorite

Novel Germline BRCA1 and BRCA2 Mutations in Turkish Women with Breast and/or Ovarian Cancer and Their Relatives

By Egeli Unal   Cecener Gulsah   Tunca Berrin   Tasdelen Ismet  

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 484-491

Informa Healthcare

Access to resources Recommend Favorite

BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast–ovarian cancer families. Identification of novel mutations and unclassified variants

By Delgado L.   Fernández G.   Grotiuz G.   Cataldi S.   González A.   LLuveras N.   Heguaburu M.   Fresco R.   Lens D.   Sabini G.   Muse I.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 211-218

Springer Publishing Company

Access to resources Recommend Favorite

Survival of BRCA1 Negative Ovarian Cancer Patients Based on Family History

By Chu C.S.   Morgan M.A.   Randall T.C.   Bandera C.A.   Rubin S.C.  

Gynecologic Oncology, Vol. 83, Iss. 1, 2001-10 ,pp. : 109-114

Elsevier

Access to resources Recommend Favorite